Atlas Trials

An Open-Labeled Exploratory Study to Evaluate Safety and Efficacy of FB825 in Adults With Atopic Dermatitis

Clinical trial NCT03758716 · COMPLETED

Trial details

NCT number
NCT03758716
Sponsor
Fountain Biopharma Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Atopic Dermatitis
Start date
2017-07-03
Primary completion
2019-01-28
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.